- Why the Top 200 Drugs Matter for the PTCE
- How Drug Knowledge Is Tested on the PTCE Exam
- Cardiovascular Drugs
- Central Nervous System (CNS) Drugs
- Endocrine and Metabolic Drugs
- Anti-Infective Drugs
- Respiratory and Gastrointestinal Drugs
- Musculoskeletal and Pain Management Drugs
- Commonly Confused Drug Names
- 7 Proven Memorization Strategies
- High-Yield Drug Facts for Exam Day
- Frequently Asked Questions
Why the Top 200 Drugs Matter for the PTCE
If there is a single topic area that can make or break your PTCE exam score, it is your knowledge of the top 200 dispensed drugs. The Medications domain accounts for 35% of the entire exam—the largest single domain on the PTCB's content outline. That means roughly 28 of the 80 scored questions will directly test your ability to match brand names to generics, identify drug classifications, recognize common indications, and flag potential safety concerns. Mastering this drug list is not optional; it is the foundation of passing the exam.
The top 200 drugs represent the most frequently prescribed medications in the United States. As a pharmacy technician, you will encounter these medications daily when processing prescriptions, verifying inventory, and assisting pharmacists with patient care. The PTCB expects candidates to demonstrate working familiarity with these drugs because they form the backbone of community and institutional pharmacy practice.
Whether you are just beginning your study journey or fine-tuning your preparation in the final weeks before exam day, this comprehensive guide organizes the top 200 drugs by therapeutic classification, pairs brand and generic names, and highlights the details that appear most frequently on the PTCE. For a broader look at tackling this critical domain, read our guide on the PTCE Medications Domain: How to Master the Largest Section of the Exam.
How Drug Knowledge Is Tested on the PTCE Exam
Understanding how the PTCE tests drug knowledge is just as important as memorizing the drug list itself. The exam does not simply ask you to match a brand name to a generic name in isolation. Instead, questions are scenario-based and may integrate drug knowledge with other domains like patient safety and order processing. Here are the most common ways drug knowledge appears on the exam:
- Brand-to-generic matching: A prescription arrives with the brand name, and you must identify the correct generic equivalent for dispensing.
- Drug classification identification: You are given a medication name and asked to identify its therapeutic class or pharmacologic category.
- Indication recognition: Questions may describe a patient's condition and ask which medication is appropriate, or give you a drug name and ask what it treats.
- Look-alike/sound-alike awareness: The exam tests your ability to distinguish between commonly confused drug names to prevent dispensing errors.
- Side effect and interaction knowledge: You may need to identify a major side effect, contraindication, or drug-drug interaction.
- DEA schedule classification: Controlled substances require you to know which schedule a drug falls under.
The PTCB updated its content outline effective January 6, 2026 (v1.4). While the Medications domain remains at 35%, the Federal Requirements domain increased from 12.5% to 18.75%, adding new DSCSA content. Drug knowledge now intersects more heavily with federal tracking and serialization requirements. Review the New 2026 PTCE Content Outline: Key Changes Every Candidate Needs to Know for full details.
To test your readiness across all these question types, try our free PTCE practice tests that mirror the actual exam format and difficulty level.
Cardiovascular Drugs
Cardiovascular medications consistently make up the largest single category within the top 200 list. Heart disease remains the leading cause of death in the United States, so these drugs appear in enormous prescription volume. You should be able to identify each drug's class, its generic and brand name pairing, and its primary indication.
ACE Inhibitors and ARBs
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Vasotec | enalapril | ACE Inhibitor | Hypertension, heart failure |
| Prinivil / Zestril | lisinopril | ACE Inhibitor | Hypertension, heart failure |
| Altace | ramipril | ACE Inhibitor | Hypertension, post-MI |
| Lotensin | benazepril | ACE Inhibitor | Hypertension |
| Cozaar | losartan | ARB | Hypertension |
| Diovan | valsartan | ARB | Hypertension, heart failure |
| Benicar | olmesartan | ARB | Hypertension |
| Atacand | candesartan | ARB | Hypertension, heart failure |
Stem tip: Generic ACE inhibitors end in -pril (lisinopril, enalapril, ramipril). Generic ARBs end in -sartan (losartan, valsartan, olmesartan). Recognizing these stems is one of the fastest ways to identify drug classes on exam day.
Beta-Blockers and Calcium Channel Blockers
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Lopressor / Toprol-XL | metoprolol | Beta-Blocker | Hypertension, angina, heart failure |
| Tenormin | atenolol | Beta-Blocker | Hypertension, angina |
| Coreg | carvedilol | Beta-Blocker | Heart failure, hypertension |
| Bystolic | nebivolol | Beta-Blocker | Hypertension |
| Norvasc | amlodipine | CCB (Dihydropyridine) | Hypertension, angina |
| Cardizem / Tiazac | diltiazem | CCB (Non-dihydropyridine) | Hypertension, angina, arrhythmia |
| Calan / Verelan | verapamil | CCB (Non-dihydropyridine) | Hypertension, angina, arrhythmia |
Stem tip: Most beta-blocker generics end in -olol (metoprolol, atenolol, carvedilol). Dihydropyridine CCBs end in -dipine (amlodipine, nifedipine).
Statins and Other Lipid-Lowering Agents
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Lipitor | atorvastatin | HMG-CoA Reductase Inhibitor | Hyperlipidemia |
| Crestor | rosuvastatin | HMG-CoA Reductase Inhibitor | Hyperlipidemia |
| Zocor | simvastatin | HMG-CoA Reductase Inhibitor | Hyperlipidemia |
| Pravachol | pravastatin | HMG-CoA Reductase Inhibitor | Hyperlipidemia |
| Zetia | ezetimibe | Cholesterol Absorption Inhibitor | Hyperlipidemia |
| Tricor | fenofibrate | Fibrate | Hypertriglyceridemia |
Stem tip: All statin generics end in -statin. Atorvastatin (Lipitor) is the most prescribed statin in the country and is virtually guaranteed to appear on your exam.
Diuretics and Anticoagulants
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Lasix | furosemide | Loop Diuretic | Edema, heart failure |
| Microzide | hydrochlorothiazide (HCTZ) | Thiazide Diuretic | Hypertension |
| Aldactone | spironolactone | Potassium-Sparing Diuretic | Heart failure, edema, hypertension |
| Coumadin | warfarin | Vitamin K Antagonist | Anticoagulation |
| Eliquis | apixaban | Direct Oral Anticoagulant (DOAC) | AFib, DVT/PE prevention |
| Xarelto | rivaroxaban | Direct Oral Anticoagulant (DOAC) | AFib, DVT/PE prevention |
| Plavix | clopidogrel | Antiplatelet | Stroke/MI prevention |
Anticoagulants like warfarin, apixaban, and rivaroxaban are classified as high-alert medications by the Institute for Safe Medication Practices (ISMP). The PTCE frequently tests your knowledge of these drugs in the context of patient safety—expect questions about INR monitoring for warfarin, reversal agents, and drug interactions. Review the PTCE Patient Safety and Quality Assurance Domain: Complete Study Guide 2026 for more on high-alert medications.
Central Nervous System (CNS) Drugs
CNS medications cover a broad range of conditions including depression, anxiety, seizure disorders, ADHD, insomnia, and pain. Many of these drugs are controlled substances, which adds a layer of federal requirement knowledge to your drug memorization.
Antidepressants
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Zoloft | sertraline | SSRI | Depression, anxiety, OCD |
| Lexapro | escitalopram | SSRI | Depression, GAD |
| Prozac | fluoxetine | SSRI | Depression, OCD, bulimia |
| Celexa | citalopram | SSRI | Depression |
| Paxil | paroxetine | SSRI | Depression, anxiety disorders |
| Effexor XR | venlafaxine | SNRI | Depression, GAD, social anxiety |
| Cymbalta | duloxetine | SNRI | Depression, neuropathic pain, fibromyalgia |
| Wellbutrin | bupropion | NDRI | Depression, smoking cessation |
| Desyrel | trazodone | SARI | Depression, insomnia |
Controlled CNS Medications
| Brand Name | Generic Name | Class | DEA Schedule |
|---|---|---|---|
| Xanax | alprazolam | Benzodiazepine | C-IV |
| Ativan | lorazepam | Benzodiazepine | C-IV |
| Valium | diazepam | Benzodiazepine | C-IV |
| Klonopin | clonazepam | Benzodiazepine | C-IV |
| Ambien | zolpidem | Non-benzo Hypnotic | C-IV |
| Adderall | amphetamine/dextroamphetamine | CNS Stimulant | C-II |
| Concerta / Ritalin | methylphenidate | CNS Stimulant | C-II |
| Lyrica | pregabalin | Anticonvulsant | C-V |
The PTCE does not only ask about drug names—it tests DEA scheduling as part of the Federal Requirements domain. Benzodiazepines are Schedule IV, ADHD stimulants are Schedule II, and pregabalin is Schedule V. Schedule II drugs require a new prescription for each fill (no refills allowed). For comprehensive federal requirements preparation, see Federal Requirements on the PTCE: What Changed in 2026 and How to Prepare.
Endocrine and Metabolic Drugs
Diabetes, thyroid disorders, and hormonal conditions generate a significant portion of the prescriptions you will encounter. Diabetes medications alone include multiple drug classes, and the PTCE expects you to differentiate between them.
Diabetes Medications
| Brand Name | Generic Name | Class | Route |
|---|---|---|---|
| Glucophage | metformin | Biguanide | Oral |
| Januvia | sitagliptin | DPP-4 Inhibitor | Oral |
| Jardiance | empagliflozin | SGLT2 Inhibitor | Oral |
| Farxiga | dapagliflozin | SGLT2 Inhibitor | Oral |
| Amaryl | glimepiride | Sulfonylurea | Oral |
| Glucotrol | glipizide | Sulfonylurea | Oral |
| Ozempic | semaglutide | GLP-1 Receptor Agonist | Injection (SQ) |
| Trulicity | dulaglutide | GLP-1 Receptor Agonist | Injection (SQ) |
| Lantus | insulin glargine | Long-Acting Insulin | Injection (SQ) |
| Humalog | insulin lispro | Rapid-Acting Insulin | Injection (SQ) |
| NovoLog | insulin aspart | Rapid-Acting Insulin | Injection (SQ) |
Stem tips: DPP-4 inhibitors end in -gliptin (sitagliptin, saxagliptin). SGLT2 inhibitors end in -gliflozin (empagliflozin, dapagliflozin). GLP-1 agonists end in -glutide (semaglutide, dulaglutide, liraglutide). These stems are essential shortcuts on exam day.
Thyroid and Hormonal Agents
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Synthroid / Levoxyl | levothyroxine | Thyroid Hormone | Hypothyroidism |
| Premarin | conjugated estrogens | Estrogen | Menopause symptoms |
| Prednisone (generic) | prednisone | Corticosteroid | Inflammation, autoimmune conditions |
| Medrol | methylprednisolone | Corticosteroid | Inflammation |
Levothyroxine is consistently one of the top 3 most prescribed drugs in the United States. Know that it should be taken on an empty stomach, 30 to 60 minutes before breakfast, and that it has numerous drug interactions including calcium and iron supplements.
Anti-Infective Drugs
Antibiotics, antivirals, and antifungals are dispensed in enormous volumes and are tested heavily on the PTCE. Pay special attention to drug allergies and cross-sensitivities, particularly within the penicillin and cephalosporin families.
| Brand Name | Generic Name | Class | Key Notes |
|---|---|---|---|
| Amoxil | amoxicillin | Penicillin | Most prescribed antibiotic |
| Augmentin | amoxicillin/clavulanate | Penicillin + Beta-lactamase Inhibitor | Broader spectrum than amoxicillin alone |
| Keflex | cephalexin | 1st-Gen Cephalosporin | Cross-allergy risk with penicillin |
| Zithromax / Z-Pack | azithromycin | Macrolide | Often used in penicillin allergy |
| Cipro | ciprofloxacin | Fluoroquinolone | FDA black box warning |
| Levaquin | levofloxacin | Fluoroquinolone | FDA black box warning |
| Bactrim / Septra | sulfamethoxazole/trimethoprim | Sulfonamide Combination | Sulfa allergy risk |
| Flagyl | metronidazole | Nitroimidazole | Avoid alcohol (disulfiram reaction) |
| Diflucan | fluconazole | Azole Antifungal | Numerous drug interactions |
| Valtrex | valacyclovir | Antiviral | Herpes, shingles |
| Tamiflu | oseltamivir | Neuraminidase Inhibitor | Influenza (must start within 48 hrs) |
Ciprofloxacin and levofloxacin carry FDA black box warnings for tendon rupture, peripheral neuropathy, and CNS effects. The PTCE may test your awareness of this warning. Additionally, fluoroquinolones should not be taken with divalent cations (calcium, magnesium, iron, aluminum) as they reduce absorption.
Respiratory and Gastrointestinal Drugs
Respiratory Medications
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| ProAir / Ventolin | albuterol | Short-Acting Beta-2 Agonist (SABA) | Asthma rescue |
| Advair | fluticasone/salmeterol | ICS/LABA Combination | Asthma, COPD maintenance |
| Symbicort | budesonide/formoterol | ICS/LABA Combination | Asthma, COPD maintenance |
| Spiriva | tiotropium | Long-Acting Anticholinergic (LAMA) | COPD maintenance |
| Singulair | montelukast | Leukotriene Receptor Antagonist | Asthma, allergic rhinitis |
| Flonase | fluticasone (nasal) | Intranasal Corticosteroid | Allergic rhinitis |
Gastrointestinal Medications
| Brand Name | Generic Name | Class | Primary Indication |
|---|---|---|---|
| Prilosec | omeprazole | Proton Pump Inhibitor (PPI) | GERD, ulcers |
| Nexium | esomeprazole | Proton Pump Inhibitor (PPI) | GERD, ulcers |
| Protonix | pantoprazole | Proton Pump Inhibitor (PPI) | GERD, ulcers |
| Pepcid | famotidine | H2 Receptor Antagonist | GERD, heartburn |
| Zofran | ondansetron | 5-HT3 Antagonist | Nausea and vomiting |
| Reglan | metoclopramide | Dopamine Antagonist | GERD, gastroparesis |
| Linzess | linaclotide | Guanylate Cyclase-C Agonist | IBS-C, chronic constipation |
Stem tip: All PPI generics end in -prazole (omeprazole, pantoprazole, esomeprazole, lansoprazole). This is one of the easiest stems to recognize on the exam.
Musculoskeletal and Pain Management Drugs
| Brand Name | Generic Name | Class | DEA Schedule |
|---|---|---|---|
| Tylenol | acetaminophen | Analgesic/Antipyretic | Not controlled |
| Advil / Motrin | ibuprofen | NSAID | Not controlled |
| Celebrex | celecoxib | COX-2 Selective NSAID | Not controlled |
| Norco / Vicodin | hydrocodone/acetaminophen | Opioid Combination | C-II |
| Percocet | oxycodone/acetaminophen | Opioid Combination | C-II |
| OxyContin | oxycodone ER | Opioid | C-II |
| Ultram | tramadol | Opioid Agonist | C-IV |
| Neurontin | gabapentin | Anticonvulsant (off-label pain) | C-V (some states) |
| Flexeril | cyclobenzaprine | Muscle Relaxant | Not controlled |
All hydrocodone combination products were reclassified from Schedule III to Schedule II in 2014. This remains a frequently tested fact. Tramadol is scheduled as C-IV federally, making it the only commonly prescribed opioid with refill capability (up to 5 refills within 6 months). Gabapentin scheduling varies by state—know that some states have classified it as C-V.
Commonly Confused Drug Names
The PTCE places significant emphasis on look-alike/sound-alike (LASA) drug names as part of the Patient Safety and Quality Assurance domain. Confusing these medications can cause serious patient harm. Here are the most commonly tested pairs:
| Drug A | Drug B | Why They're Confused |
|---|---|---|
| hydroxyzine (antihistamine) | hydralazine (antihypertensive) | Similar spelling and pronunciation |
| metformin (diabetes) | metronidazole (antibiotic) | Both start with "met-" |
| prednisone (corticosteroid) | prednisolone (corticosteroid) | Nearly identical names, different formulations |
| clonidine (antihypertensive) | clonazepam (benzodiazepine) | Similar first syllables |
| bupropion (antidepressant) | buspirone (anxiolytic) | Similar spelling and sound |
| Celebrex (celecoxib) | Celexa (citalopram) | Nearly identical brand names |
| lamotrigine (anticonvulsant) | lamivudine (antiviral) | Similar spelling |
Memorizing these LASA pairs is a direct path to earning points on the exam. Use the ISMP's published list of confused drug names as a study resource, and test your recall with PTCE practice questions that specifically target these safety concepts.
7 Proven Memorization Strategies
Knowing that you need to learn over 200 drugs is daunting. These seven strategies are used by successful candidates who passed the PTCE on their first attempt. For a complete study framework, visit our How to Pass the PTCE Exam on Your First Attempt: Complete Study Guide 2026.
Before memorizing individual drugs, learn the common generic stems. Knowing that -statin means HMG-CoA reductase inhibitor, -pril means ACE inhibitor, and -olol means beta-blocker allows you to classify unfamiliar drugs instantly. This one technique can help you answer questions about drugs you have never specifically studied.
Organize your study sessions by therapeutic class (cardiovascular, CNS, anti-infective, etc.) rather than alphabetical order. This creates logical associations in your memory. When you study all statins together, you reinforce the pattern—they all lower cholesterol, all end in -statin, and all carry similar side effects like myalgia.
Create flashcards (physical or digital) with the brand name on one side and the generic name, class, and indication on the other. Review using a spaced repetition system that shows you cards you struggle with more frequently while spacing out cards you know well. Apps like Anki are ideal for this method.
If you work in a pharmacy, pay close attention to the medications you process daily. When you fill a prescription for atorvastatin, mentally review: brand name Lipitor, HMG-CoA reductase inhibitor, used for hyperlipidemia, common side effect is muscle pain. Contextual learning is far more durable than rote memorization.
For drugs that don't follow clean stem patterns, create personalized mnemonics. For example: "Warfarin is a WAR on clots" (anticoagulant). "Singulair is a SINGLE tablet for breathing" (montelukast for asthma). The sillier the mnemonic, the more likely you are to remember it under exam pressure.
Do not try to memorize all 200 drugs in one sitting. Break them into manageable groups of 10 to 15 drugs per study session. Review previous groups at the start of each session before adding new ones. Following a structured plan like our 30-Day PTCE Study Plan ensures consistent progress without burnout.
Apply your knowledge in an exam-like setting at least twice a week. Practice tests reveal which drugs you actually know versus which ones you only think you know. Our free PTCE practice exams include drug-specific questions that simulate the difficulty and format of the real PTCE.
High-Yield Drug Facts for Exam Day
Beyond brand-generic matching, the PTCE expects you to know certain high-yield clinical facts about commonly tested medications. These are the details that separate a passing score from a failing one.
- Metformin should be held before and after contrast dye procedures due to risk of lactic acidosis.
- Warfarin interacts with vitamin K-rich foods, and patients require regular INR monitoring (target 2.0–3.0 for most indications).
- Amoxicillin suspensions require refrigeration after reconstitution and have a 14-day beyond-use date.
- Methotrexate is dosed weekly (not daily) for autoimmune conditions—daily dosing is a common fatal error.
- Nitroglycerin sublingual tablets expire quickly once opened and should be stored in the original glass container.
- Albuterol inhalers should be primed before first use and after extended periods without use.
- Levothyroxine has narrow therapeutic index—brand-to-generic substitution may not be appropriate without physician approval in some states.
- ACE inhibitors can cause a persistent dry cough; switching to an ARB often resolves the issue.
- Statins are typically dosed at bedtime (especially simvastatin) because cholesterol synthesis peaks at night.
- Isotretinoin (Accutane) requires the iPLEDGE program due to severe teratogenic risk.
Some exam questions combine drug knowledge with pharmacy calculations. You might be asked to calculate a days' supply for metformin 500 mg taken twice daily with a quantity of 60 tablets, or determine the correct dose of amoxicillin suspension for a pediatric patient based on weight. Brush up on these intersecting skills with our guide to PTCE Math and Calculations: Formulas, Conversions, and Practice Problems for 2026.
Understanding these high-yield facts transforms your drug knowledge from simple memorization into applied pharmacy competence—exactly what the PTCB is testing for. If you are wondering whether the effort is worth it, consider that earning your CPhT opens doors to higher pay and advancement opportunities. Learn more about the financial return in our article on Certified Pharmacy Technician Salary 2026: How CPhT Certification Boosts Your Earnings.
Frequently Asked Questions
While you may not be tested on every single drug from the top 200 list, the Medications domain makes up 35% of the exam. Candidates who thoroughly study the top 200 drugs consistently score higher. Focus your effort on the most commonly prescribed drugs in each major therapeutic class, and learn the generic stems that allow you to identify unfamiliar medications by their name endings. Most successful candidates aim to know at least 150 to 180 of the top 200 drugs confidently.
The PTCE goes well beyond simple name matching. You should expect questions about drug indications (what condition a drug treats), major side effects, drug interactions, storage requirements, DEA scheduling for controlled substances, and look-alike/sound-alike safety concerns. Questions are presented in scenario-based formats that integrate drug knowledge with real pharmacy practice situations. Prepare by studying drugs holistically—not just their names.
Start by creating a master list of the 20 to 25 most common stems (such as -statin, -pril, -sartan, -olol, -prazole, -dipine, -gliptin, -gliflozin, and -glutide). Study one stem group per day and practice identifying unfamiliar drugs by their stems. Within two to three weeks, you will be able to classify most medications by their generic name alone. This strategy is especially powerful for eliminating wrong answer choices on the exam.
The PTCE contains 90 total questions, of which 80 are scored and 10 are unscored pretest items. The Medications domain accounts for 35% of scored content, which translates to approximately 28 scored questions directly testing drug knowledge. However, drug knowledge also supports questions in other domains—for example, recognizing a look-alike drug name falls under Patient Safety (23.75%), and knowing a controlled substance schedule relates to Federal Requirements (18.75%). In practice, drug knowledge impacts well over half of all exam questions.
The PTCB focuses on medications that are well-established in pharmacy practice. Brand-new drugs that received FDA approval within the last 6 to 12 months are unlikely to appear on the exam. The PTCB content outline is updated periodically—the most recent update took effect January 6, 2026—but the drug-related content emphasizes widely dispensed medications that pharmacy technicians encounter daily. Focus your study time on the top 200 most dispensed drugs rather than chasing the newest approvals.
Ready to Start Practicing?
You have studied the top 200 drugs—now put your knowledge to the test. Our PTCE practice exams include questions on brand and generic names, drug classifications, controlled substance scheduling, and look-alike/sound-alike medications. See exactly where you stand before exam day.
Start Free Practice Test →